Alcidion Group Limited

ALC

AU000000ALC6

Software

Market Closed - Australian S.E. Other stock markets 01:56:36 2024-06-07 EDT			5-day change	1st Jan Change
0.049 ^AUD	-2.97%		-15.52%	-34.67%

04-18	Alcidion Logs AU$10 Million Cash Receipts in Fiscal Q3	MT
04-18	Alcidion Group Limited Provides Revenue Guidance for the Second Half of 2024	CI

Alcidion Group Limited Announces the Cessation of Geoff Rohrsheim as Director

July 30, 2019 at 06:38 pm

Alcidion Group Limited announced the cessation of Geoff Rohrsheim as director effective 30 June 2019.

Latest news about Alcidion Group Limited

Alcidion Logs AU$10 Million Cash Receipts in Fiscal Q3	04-17	MT
Alcidion Group Limited Provides Revenue Guidance for the Second Half of 2024	04-17	CI
Transcript : Alcidion Group Limited, Q3 2024 Earnings Call, Apr 18, 2024	04-17
Alcidion Group Extends Contract with Dartford and Gravesham NHS Trust; Shares Down 4%	03-05	MT
Transcript : Alcidion Group Limited, H1 2024 Earnings Call, Feb 28, 2024	02-27
Alcidion Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-27	CI
Transcript : Alcidion Group Limited, Q2 2024 Earnings Call, Jan 31, 2024	01-30
Alcidion Group Nabs Eight-Year Contract Extension With South Tees Hospital NHS Foundation Trust	12-11	MT
Transcript : Alcidion Group Limited - Shareholder/Analyst Call	11-19
Alcidion Group Opens AU$1 Million Share Purchase Plan; Shares Slide 4%	11-09	MT
Transcript : Alcidion Group Limited, 2023 Earnings Call, Aug 24, 2023	23-08-23
Alcidion Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-23	CI
Transcript : Alcidion Group Limited, Q4 2023 Earnings Call, Jul 27, 2023	23-07-26
Alcidion Group Secures Two Contract Renewals	23-05-30	MT
Transcript : Alcidion Group Limited, Q3 2023 Earnings Call, Apr 27, 2023	23-04-26
Alcidion Group Limited(ASX:ALC) dropped from S&P/ASX All Ordinaries Index	23-03-20	CI
Transcript : Alcidion Group Limited, H1 2023 Earnings Call, Feb 24, 2023	23-02-23
Alcidion Group Limited Provides Revenue Guidance for the Fiscal Year 2023	23-02-23	CI
Alcidion Group Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Transcript : Alcidion Group Limited, H1 2023 Earnings Call, Jan 30, 2023	23-01-29
Alcidion Group Extends Partnership with Leidos Australia; Shares Rise 7%	22-12-18	MT
Alcidion Group Limited Extends Partnership with Leidos Australia and Commonwealth of Australia	22-12-18	CI
Alcidion Secures Three-Year Deal for Medical Record Platform	22-12-01	MT
Alcidion Group Limited Signs an Initial 3 Year Agreement with University Hospital Southampton NHS Foundation Trust to Implement its Miya Precision Platform	22-11-30	CI
Alcidion Group Limited Announces Malcolm Pradhan Stepping Down as Executive Director and Chief Medical Officer	22-11-01	CI

Alcidion Group Limited is a healthcare technology company. The Company's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The Company's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.

Sector

Software

Calendar

2024-08-27 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Alcidion Group Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.049 AUD

Average target price

0.08 AUD

Spread / Average Target

+63.27%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
ALCIDION GROUP LIMITED	-34.67%	43.31M
MICROSOFT CORPORATION	+12.71%	3,150B
SYNOPSYS INC.	+10.98%	87.56B
CADENCE DESIGN SYSTEMS, INC.	+8.10%	80.72B
DASSAULT SYSTÈMES SE	-16.04%	52.81B
PALANTIR TECHNOLOGIES INC.	+35.76%	51.91B
THE TRADE DESK, INC.	+30.86%	46.06B
ATLASSIAN CORPORATION	-31.32%	42.52B
SEA LIMITED	+78.94%	41.62B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	+2.37%	28.24B

Other Software